title: Effects of acetylcholinesterase inhibitor paraoxon denote the possibility of non-quantal acetylcholine release in myocardium of different vertebrates.
abstract: Effects of organophosphorous acetylcholinesterase inhibitor paraoxon were studied in the isolated atrial and ventricular myocardium preparations of a fish (cod), an amphibian (frog) and a mammal (rat) using the microelectrode technique. Incubation of isolated atrium with paraoxon (5 × 10(-6)-5 × 10(-5) M) caused significant reduction of action potential duration and marked slowing of sinus rhythm. These effects were abolished by muscarinic blocker atropine and therefore are caused by acetylcholine, which accumulates in the myocardium due to acetylcholinesterase inhibition even in the absence of vagal input. Hemicholinium III is a blocker of high affinity choline-uptake transporters, which are believed to mediate non-quantal release of acetylcholine from cholinergic terminals in different tissues. In the atrial myocardium of all the three studied species, hemicholinium III (10(-5) M) significantly suppressed all the effects of paraoxon. Blocker of parasympathetic ganglionic transmission hexamethonium bromide (10(-4) M) and inhibitor of vesicular acetylcholine transporters vesamicol (10(-5) M) failed to attenuate paraoxon effects. Among ventricular myocardium preparations of three species paraoxon provoked marked cholinergic effects only in frog, hemicholinium III abolished these effects effectively. We conclude that paraoxon stops degradation of acetylcholine in the myocardium and helps to reveal the effects of acetylcholine, which is continuously secreted from the cholinergic nerves in non-quantal manner. Thus, non-quantal release of acetylcholine in the heart is not specific only for mammals, but is also present in the hearts of different vertebrates.
authors.affiliation: Department of Human and Animal Physiology, Moscow State University, Leninskiye Gory, 1, 12, Moscow, Russia. abram340@mail.ru
authors.forename: Denis V
authors.initials: DV
authors.lastname: Abramochkin
authors.forename: Anastasia A
authors.initials: AA
authors.lastname: Borodinova
authors.forename: Leonid V
authors.initials: LV
authors.lastname: Rosenshtraukh
mesh_terms: D000109:Acetylcholine / Q000378:metabolism*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D048389:Gadus morhua / Q000378:metabolism; D006321:Heart / Q000187:drug effects; D006325:Heart Atria / Q000187:drug effects / Q000378:metabolism; D006352:Heart Ventricles / Q000187:drug effects / Q000378:metabolism; D006426:Hemicholinium 3 / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D010261:Paraoxon / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology; D011896:Rana temporaria / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D014714:Vertebrates / Q000378:metabolism*
chemical_list: D002800:Cholinesterase Inhibitors; D010880:Piperidines; D006426:Hemicholinium 3; C006189:vesamicol; D001285:Atropine; D000109:Acetylcholine; D010261:Paraoxon